Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May;113(5):367-368.
doi: 10.1016/j.acvd.2020.04.001. Epub 2020 Apr 15.

Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes

Christian Funck-Brentano  1 , Joe-Elie Salem  2 , Lee S Nguyen  3 , Milou-Daniel Drici  4 , Dan M Roden  5
Affiliations
Comment

Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes

Christian Funck-Brentano et al. Arch Cardiovasc Dis. 2020 May.
No abstract available

Keywords: Azithromycin; Azithromycine; Chloroquine; Hydroxychloroquine; Long QT syndrome; Syndrome du QT long; Torsade de Pointes.

PubMed Disclaimer

Comment on

References

    1. Hulot J.S. COVID-19 in patients with cardiovascular diseases. Arch Cardiovasc Dis. 2020 doi: 10.1016/j.acvd.2020.03.009. [in press] - DOI - PMC - PubMed
    1. Borsini F., Crumb W., Pace S., et al. In vitro cardiovascular effects of dihydroartemisin–piperaquine combination compared with other anti-malarials. Antimicrob Agents Chemother. 2012;56:3261–3270. - PMC - PubMed
    1. Vicente J., Zusterzeel R., Johannesen L., et al. Assessment of multi-ion channel block in a phase I randomised study design: results of the CiPA phase I ECG biomarker validation study. Clin Pharmacol Ther. 2019;105:943–953. - PMC - PubMed
    1. Chen C.Y., Wang F.L., Lin C.C. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol (Phila) 2006;44:173–175. - PubMed
    1. Yang Z., Prinsen J.K., Bersell K.R., et al. Azithromycin causes a novel proarrhythmic syndrome. Circ Arrhythm Electrophysiol. 2017;10:e003560. - PMC - PubMed